Protein Summary
- ENST00000376557
- ENSP00000365740
- ENSG00000204576
- ENST00000376560
- ENSP00000365744
- ENST00000383592
- ENSP00000373086
- ENSG00000206491
- ENST00000418065
- ENSP00000404669
- ENST00000422140
- ENSP00000411802
- ENSG00000228186
- ENST00000422639
- ENSP00000401499
- ENSG00000229202
- ENST00000427729
- ENSP00000402596
- ENSG00000223766
- ENST00000432371
- ENSP00000396416
- ENST00000436805
- ENSP00000406321
- ENSG00000233564
- ENST00000442290
- ENSP00000401612
- ENSG00000223887
- ENST00000444972
- ENSP00000393410
- ENST00000449754
- ENSP00000398352
- ENST00000453232
- ENSP00000415432
- ENST00000454399
- ENSP00000392826
- CAT56
- CAT56
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
cellular component | 0.75 | ||
transcription factor | 0.74 | ||
microRNA | 0.71 | ||
small molecule perturbation | 0.64 | ||
cell type or tissue | 0.62 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 0.59 (req: < 5)
Gene RIFs: 1 (req: <= 3)
Antibodies: 28 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 0.59 (req: >= 5)
Gene RIFs: 1 (req: > 3)
Antibodies: 28 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 2
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0